On average, Mochi Health members lose 36 pounds in their first year, and most sustain their weight loss much longer than they ...

Losing weight is a top New Year’s resolution. But this year, doctors might prescribe more than just diet and exercise.

Weight-loss experts reveal their major predictions for 2026, from advanced GLP-1 treatments to AI-driven personalized therapy ...

The first oral GLP-1 medication for weight loss has been approved for use in the U.S. The Wegovy pill, from drugmaker Novo Nordisk, was cleared by the Food and Drug Administration to reduce excess ...

WW International (WW), more commonly known as Weight Watchers, is fully embracing the popularity of GLP-1s and their impact on weight loss management with a new platform that integrates GLP-1 ...

In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side effects. By Paula Span Year after year, Mary Bucklew strategized with a ...

Ozempic started the weight-loss drug frenzy, and it continues to be a famous name in the fight against obesity, even though it's not approved for that purpose. The blockbuster medication is meant to ...

When Novo Nordisk launched Wegovy, its pioneering weight-loss jab, in America in June 2021, it felt like it was “running into a dark tunnel”, recalls Maziar Mike Doustdar, who took over as the Danish ...

People turning to injectable GLP-1 treatments—a class of drugs that mimics that hormone to control diabetes and promote weight loss—now have another way to take the medication. On Dec. 22, the U.S.

Baltimore's season is now on the brink after blowing an 11-point fourth-quarter lead to fall to New England. Patrick Smith / Getty Images BALTIMORE — All the elements were in place from so many ...

Novo Nordisk’s Wegovy weight loss pill hit U.S. pharmacies this week. Here’s how it works, who qualifies, how to take it, ...